U.S. Markets close in 3 hrs 43 mins

Rite Aid Corporation (RAD)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
2.535-0.095 (-3.612%)
As of 12:17PM EDT. Market open.
People also watch
Full screen
Previous Close2.630
Bid2.530 x 69100
Ask2.540 x 62800
Day's Range2.480 - 2.620
52 Week Range2.210 - 8.770
Avg. Volume34,756,996
Market Cap2.67B
PE Ratio (TTM)-39.61
EPS (TTM)-0.06
Earnings DateSep 20, 2017 - Sep 25, 2017
Dividend & Yield0.00 (0.00%)
Ex-Dividend Date1999-10-14
1y Target Est2.88
Trade prices are not sourced from all markets
  • Business Wire2 hours ago

    Rite Aid Expands Naloxone Dispensing Program to Michigan and South Carolina

    Rite Aid announced today that naloxone, a medication that can be used to reverse the effects of an opioid overdose, is now available at more than 360 pharmacies in Michigan and South Carolina without a prescription, subject to state regulations.

  • American City Business Journals21 hours ago

    Fred's names new exec to C-suite

    Fred’s Inc. — the pharmacy and general merchandise retailer that recently saw its plans of becoming the third-largest drugstore chain in the U.S. shattered — announced July 19 that Jason Jenne was appointed executive vice president and CFO of Fred’s, effective immediately. Jenne replaces Rick Hans in the position. Hans joined Fred’s in April 2016 under then-Fred’s CEO Jerry A. Shore.

  • Rite Aid Corporation (RAD) Stock Will Never Be the Same Again

    Rite Aid Corporation (RAD) Stock Will Never Be the Same Again

    The Rite Aid that will emerge from the WBA deal will be much different than the company that existed before the deal. Walgreens was going to buy RAD for $9.4 billion, or about $9 per share. The Federal Trade Commission (FTC) didn’t like that idea, so it told Walgreens and Rite Aid to go back to the drawing board.